BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
- Status
- COMPLETED
- Phase
- N/A
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer
- Status
- UNKNOWN
- Phase
- N/A
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- N/A
Trial of Poor Performance Status Patients (ToPPS)
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- N/A
Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2